Cercar

01/01/2023 m-RESIST, a Mobile Therapeutic Intervention for Treatment-Resistant Schizophrenia: Feasibility, Acceptability, and Usability Study
Grasa, E, Seppala, J, Alonso-Solis, A, Haapea, M, Isohanni, M, Miettunen, J, Mendivelso, JC, Almazan, C, Rubinstein, K, Caspi, A, Unoka, Z, Farkas, K, Usall, J, Ochoa, S, van der Graaf, S, Jewell, C, Triantafillou, A, Stevens, M, Reixach, E, Berdun, J, m RESIST Grp, Corripio, I. m-RESIST, a Mobile Therapeutic Intervention for Treatment-Resistant Schizophrenia: Feasibility, Acceptability, and Usability Study. Jmir Formative Research. 2023; 7DOI:10.2196/46179. PMID:37389933. IF:(Q/D).
01/01/2023 The polygenic basis of relapse after a first episode of schizophrenia
Segura À.-G., Prohens L., Gassó P., Rodríguez N., Garcia-Rizo C., Moreno-Izco L., Andreu-Bernabeu Á., Zorrilla I., Mane A., Rodriguez-Jimenez R., Roldán A., Sarró S., Ibáñez Á., Usall J., Sáiz P.A., Cuesta M.J., Parellada M., González-Pinto A., Berrocoso E., Bernardo M., Mas S., Mezquida G., Arbelo N., De Matteis M., Galvañ J., Duque Guerra A., Arias i Queralt L., Perez-Bacigalupe M., Gonzalez-Ortega I., Toll A., Casanovas F., Sanchez-Pastor L., Valtueña M., Pomarol-Clotet E., García-León M.Á., Butjosa A., Rubio-Abadal E., Ribeiro M., López-Ilundain J.M., Saiz-Ruiz J., León-Quismondo L., Rivero O., Ruiz P., Echevarría R.S., García-Portilla M.P.. The polygenic basis of relapse after a first episode of schizophrenia. EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2023; 75DOI:10.1016/j.euroneuro.2023.06.003. PMID:37603902. IF:(Q/D).
01/01/2023 Regional, circuit and network heterogeneity of brain abnormalities in psychiatric disorders
Segal A., Parkes L., Aquino K., Kia S.M., Wolfers T., Franke B., Hoogman M., Beckmann C.F., Westlye L.T., Andreassen O.A., Zalesky A., Harrison B.J., Davey C.G., Soriano-Mas C., Cardoner N., Tiego J., Yücel M., Braganza L., Suo C., Berk M., Cotton S., Bellgrove M.A., Marquand A.F., Fornito A.. Regional, circuit and network heterogeneity of brain abnormalities in psychiatric disorders. NATURE NEUROSCIENCE. 2023; 26(9)DOI:10.1038/s41593-023-01404-6. PMID:37580620. IF:21.300(Q1/1D).
01/01/2023 A truly patient-centred evaluation of opioid agonist treatment
Trujols J., Vicent-Gil M., Duran-Sindreu S., Portella M.J.. A truly patient-centred evaluation of opioid agonist treatment. LANCET PSYCHIATRY. 2023; 10(8)DOI:10.1016/S2215-0366(23)00202-X. PMID:37479338. IF:(Q/D).
01/01/2023 Non-suicidal self-injury in young adults with and without borderline personality disorder: the role of emotion dysregulation and negative urgency
Schmidt C., Briones-Buixassa L., Nicolaou S., Soler J., Pascual J.C., Vega D.. Non-suicidal self-injury in young adults with and without borderline personality disorder: the role of emotion dysregulation and negative urgency. Anales de Psicologia. 2023; 39(3)DOI:10.6018/analesps.492631. PMID:. IF:1.400(Q3/8D).
01/01/2023 The Toronto Mindfulness Scale and the State Mindfulness Scale: psychometric properties of the Spanish versions
Navarrete J., Fontana-McNally M., Colomer-Carbonell A., Sanabria-Mazo J.P., Pinazo D., Silvestre-López A.-J., Lau M., Tanay G., García-Campayo J., Demarzo M., Soler J., Cebolla A., Feliu-Soler A., Luciano J.V.. The Toronto Mindfulness Scale and the State Mindfulness Scale: psychometric properties of the Spanish versions. Frontiers in Psychology. 2023; 14DOI:10.3389/fpsyg.2023.1212036. PMID:37484107. IF:2.600(Q2/3D).